PATENT CLAIM ANALYSIS

Application Number: 15927170
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

Claim (Index 88):
A method of inhibiting a BET protein comprising contacting a compound of  claim 1 , or a pharmaceutically acceptable salt thereof, with said BET protein.

Metadata:
- Claim Count in Document: 126.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14554306', '15354223', '15088373', '14554263', '15906163']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8322423091084951
- 35 USC 102 Novelty (BERT): 0.6384268716638087
- Combined Prediction Score: 0.8128607653640264
- Mean Citation Score: 555.065632
- Max Citation Score: 614.763
- Similarity Product: 575.1873856358529

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test